Piramal Enterprises board approves scheme for pharma biz demerger
The pharmaceuticals business will get demerged from Piramal Enterprises (PEL) and consolidated in Piramal Pharma, Piramal Enterprises said in a regulatory filing.
Piramal Enterprises on Thursday said its board has approved a composite scheme of arrangement providing for the demerger of its pharmaceuticals business and simplification of the corporate structure to create two listed entities in financial services and pharmaceuticals.
The pharmaceuticals business will get demerged from Piramal Enterprises (PEL) and consolidated in Piramal Pharma, Piramal Enterprises said in a regulatory filing.
See Zee Business Live TV Streaming Below:
The amalgamation of PHL Fininvest with PEL will create a listed non-banking financial services entity, it added.
The merged housing finance company, post DHFL acquisition, will remain a 100 per cent subsidiary of Piramal Enterprises, the filing said.
Shares of Piramal Enterprises were trading at Rs 2,924.45 per scrip on BSE, up 2.90 per cent from its previous close.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Shark Tank India: This startup gets blank check offer as revenue soars 10 times in 15 months, resulted in clash between judges
Tata Steel share price target: Tata group stock in focus post-Q4 results, 360% dividend announcement; should you buy or wait?
EDLI Scheme: Do you know EPFO provides Rs 7 lakh insurance cover to every member? Know about calculation, contribution, and claim process
Top 5 Defence PSU Stocks: Investors buying 1 unit of top PSU defence stock a month made Rs 40,299.40 on Rs 23,003.25 investment in 1 year
Central Railways' 63-hour mega block to hit Mumbai local train services, check dates and other details
04:02 PM IST